White House officials reportedly told governors on a call May 11 that the supply of Johnson & Johnson vaccines wouldn’t be available for states to order next week. It’s unclear if the federal government will ship any doses of the shot to pharmacy chains or community health centers, Politico reported.
States, tribes and territories have received less than 1.5 million doses of Johnson & Johnson’s vaccine in the last two weeks, since the government lifted a recommended pause on the use of the shot, according to Politico.
The White House told states this spring to expect the supply of Johnson & Johnson’s vaccine to ramp up at the end of April, but that was before problems at Emergent BioSolutions’ production plant in Maryland, where 15 million doses were ruined after a mix-up in the vaccine’s ingredients.
Johnson & Johnson has been importing vaccine doses from a facility in the Netherlands, but also has to fulfill vaccine orders from other countries. A Merck facility that will produce the shots in the U.S. won’t be ready until September, Politico reported.
The White House, HHS and Johnson & Johnson did not respond to Politico’s requests for comment.
Read the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.